From: The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development
 |  |  |  |  |  |  |  | 95% Confidence Interval for Exp(B) | |
---|---|---|---|---|---|---|---|---|---|
grade a | B | Std. Error | Wald | df | Sig. | Exp(B) | Lower Bound | Upper Bound | |
III | Intercept | ,38 | 3,21 | ,01 | 1 | ,91 | Â | Â | Â |
 | Sex | -1,20 | 1,42 | ,72 | 1 | ,40 | ,30 | ,02 | 4,84 |
 | Age | ,55 | ,78 | ,49 | 1 | ,48 | 1,73 | ,37 | 8,05 |
 | [XPC (A/C) = AA] | -,01 | ,82 | ,00 | 1 | ,98 | ,98 | ,20 | 4,90 |
 | [XPC (A/C) = AC] | ,14 | ,75 | ,03 | 1 | ,86 | 1,15 | ,26 | 4,98 |
 | [XPC (A/C) = CC] | 0b | . | . | 0 | . | . | . | . |
 | [ERCC2 (A/C) = AA] | ,43 | ,92 | ,21 | 1 | ,64 | 1,53 | ,25 | 9,30 |
 | [ERCC2 (A/C) = AC] | -,29 | ,97 | ,09 | 1 | ,76 | ,74 | ,11 | 4,96 |
 | [ERCC2 (A/C) = CC] | 0b | . | . | 0 | . | . | . | . |
 | [ERCC5 (G/C) = CC] | ,58 | ,89 | ,42 | 1 | ,52 | 1,78 | ,31 | 10,26 |
 | [ERCC5 (G/C) = GC] | -,08 | ,58 | ,02 | 1 | ,89 | ,92 | ,30 | 2,88 |
 | [ERCC5 (G/C) = GG] | 0b | . | . | 0 | . | . | . | . |
 | [PY = 0] | 1,93 | ,82 | 5,54 | 1 | ,02 | 6,89 | 1,38 | 34,33 |
 | [PY = 1-19] | -18,32 | ,00 | . | 1 | . | 1,10 | 1,10 | 1,10 |
 | [PY ≥ 20] | 0b | . | . | 0 | . | . | . | . |